Medmen Enterprises Class Performance
| MMNFFDelisted Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medmen Enterprises are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medmen Enterprises Class has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Medmen Enterprises is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 11.9 M | |
| Total Cashflows From Investing Activities | -10.9 M |
Medmen |
Medmen Enterprises Relative Risk vs. Return Landscape
If you would invest 0.01 in Medmen Enterprises Class on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Medmen Enterprises Class or generate 0.0% return on investment over 90 days. Medmen Enterprises Class is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Medmen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medmen Enterprises Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medmen Enterprises' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Medmen Enterprises Class, and traders can use it to determine the average amount a Medmen Enterprises' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MMNFF |
Based on monthly moving average Medmen Enterprises is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medmen Enterprises by adding Medmen Enterprises to a well-diversified portfolio.
Medmen Enterprises Fundamentals Growth
Medmen OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Medmen Enterprises, and Medmen Enterprises fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medmen OTC Stock performance.
| Return On Asset | -0.0522 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 390.25 M | |||
| Shares Outstanding | 1.3 B | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 140.81 M | |||
| EBITDA | (106.73 M) | |||
| Cash And Equivalents | 13.53 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 206.38 M | |||
| Debt To Equity | 7.54 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (62.53 M) | |||
| Earnings Per Share | (0.14) X | |||
| Total Asset | 323.22 M | |||
About Medmen Enterprises Performance
By analyzing Medmen Enterprises' fundamental ratios, stakeholders can gain valuable insights into Medmen Enterprises' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medmen Enterprises has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medmen Enterprises has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MEDMEN ENTERPRISES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 428 people.Things to note about Medmen Enterprises Class performance evaluation
Checking the ongoing alerts about Medmen Enterprises for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Medmen Enterprises Class help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medmen Enterprises is not yet fully synchronised with the market data | |
| Medmen Enterprises has some characteristics of a very speculative penny stock | |
| Medmen Enterprises has a very high chance of going through financial distress in the upcoming years | |
| Medmen Enterprises Class has accumulated 206.38 M in total debt with debt to equity ratio (D/E) of 7.55, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medmen Enterprises Class has a current ratio of 0.49, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Medmen Enterprises until it has trouble settling it off, either with new capital or with free cash flow. So, Medmen Enterprises' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medmen Enterprises Class sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medmen to invest in growth at high rates of return. When we think about Medmen Enterprises' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 140.81 M. Net Loss for the year was (195.19 M) with profit before overhead, payroll, taxes, and interest of 69.73 M. | |
| Medmen Enterprises Class has accumulated about 13.53 M in cash with (62.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Medmen Enterprises' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medmen Enterprises' stock is overvalued or undervalued compared to its peers.
- Examining Medmen Enterprises' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medmen Enterprises' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medmen Enterprises' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Medmen Enterprises' otc stock. These opinions can provide insight into Medmen Enterprises' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |